Thus, considering the large number of genes and mutations that can account for the FA disease, the insertion of a functional FA gene in a ‘safe harbor’ locus would lead to the generation of a targeted gene addition platform with a broad application in FA, regardless of the complementation group and mutation type of each patient. Here, FANCA is linked to Friedreich ataxia.